Welcome to BioSpherix!

Discover BioSpherix, a pioneer in advanced cell and tissue culture technology, committed to delivering Cytocentric® environments for optimal cell care.

Our range of products reflects this philosophy, including precision gas controllers, incubator subchambers, and our flagship Xvivo System®.

The Xvivo System® is modular and economical, featuring patented self-sanitizing technology that provides a superior alternative to conventional open systems, which expose cell and tissue products to variable and non-physiologic conditions.

Our philosophy is Cytocentric®: putting the needs of cells first

Physiologic

BioSpherix products create optimal, physiologic environments for cells, crucial for obtaining accurate research data.

↑ Cell viability
↑ Credibility
↑ Reproducibility

 

Economical

The optimal care of cells not only ensures accurate data but also enhances economic efficiency.

↓ Operation costs
↓ Gas and reagent use
↓ Cleaning and supplies costs 

 

Customizable

BioSpherix products, including our Xvivo Systems®, can be tailored to meet your diverse research or manufacturing needs.

+ Modular
+ Scalable
+ Technician-friendly

 

Quality

Cytocentric® technology ensures higher quality cells for better quality data and results.

+ Self-sanitizing
↓ Contamination
↑ Process control

 

{

The BioSpherix System provides an operational advantage through reduced processing times and less time spent gowning-up.

Australian Red Cross
{

We provide a constant physiologic environment with the Xvivo, so we’re hitting the cells with only defined components and we know exactly what we’re changing. We put the cell at the center and it works.

Michael Gilkey
CEO
Trailhead Biosystems
{

If you could look into the future, this would be the future of organ transplantation…This is much more elegant and much safer. This is like a new chapter in medicine.

Dr. Richard Pearl
Surgeon-in-Chief
University of Illinois College of Medicine at Peoria
{

The Xvivo barrier isolator system for cells was the answer to our prayers. Their technology allowed us to safely build a new trachea for our patient and virtually eliminated the risk of contamination

Dr. Mark Holterman
Professor of Surgery and Pediatrics
University of Illinois College of Medicine at Peoria
{

The enhanced flexibility of the system allows me to have reduced staffing and staff flexibility. Technicians efficiently move back and forth within reduced classification suites. In addition, the enhanced reagent flow in and out of the operating space is a plus for our multiple trials. Another advantage of the technology is our ability to separate our processes – if we make changes to one unit the rest of them are unchanged.

David Courtman, PhD
OHRI
{

Bristol-Myers Squibb selected the BioSpherix Isolator for the soft, clear design of the isolator fact and its tactile gloves. We also especially liked the versatility provided by the modular units that made customizing modules of different configurations very easy. At FAT, the team was impressed with the ability of the Isolator to rapidly clear particle counts.

Sr. Process Engineer
Bristol-Myers Squibb
{

“The other big advantage is between BioSpherix isolators vs. traditional stainless steel isolators, is that I can rearrange these modules however I want. That is a huge advantage when developing a strategy for cell therapy replacement. There’s a lot we don’t know, so modularity is key.”

Budd Tucker PhD
Director
Steven W. Dezii Translational Vision Facility
{

Thank you, BioSpherix, for the good equipment you have provided us. It gave us the necessary tools to study MSC in their adequate environments (Normoxia, Hypoxia and Anoxia). Well done!

Adrian Moya PhD
University of Miami
PTRME
CAS
Amercare